In cancer, a sort of chronic inflammation with the presentation of tumor antigens persists, and multiple inhibitory receptors, such as CTLA-4, PD-1, PD-L1, LAG-3 and Tim-3, are permanently expressed, especially in MSI-H CRCs with a high immunoscore. This evidence concerns the gene LAG3 and neoplasm.